RSVpreF for Prevention of Lower Respiratory Tract Disease due to Respiratory Syncytial Virus in Older Adults

May 22, 2023 | Emerging Technology Report

RSVPreF is an investigational recombinant RSV antigen vaccine for adults ≥ 60 years of age.

If you have a Hayes login, click here to view the full report on the Knowledge Center.